ARTICLE | Company News
Bolder BioTechnology other research news
January 17, 2005 8:00 AM UTC
Bolder announced that National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $500,000 Phase I SBIR grant to optimize the manufacturing process and perform preclinical toxic...